CD19 and systemic lupus erythematosus: Szabó et al43 also revealed that the percentage of plasmablasts (CD19+CD38hiCD27hi) is significantly increased in the peripheral blood of patients with SLE, exhibiting a SLEDAI score greater than 6 points.